tiprankstipranks
Avidity Biosciences: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
PremiumRatingsAvidity Biosciences: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
4d ago
Avidity Biosciences reports Q4 EPS (80c), consensus (78c)
Premium
The Fly
Avidity Biosciences reports Q4 EPS (80c), consensus (78c)
4d ago
Avidity Biosciences: Undervalued Entry Point with Promising 2025 Pipeline Despite Market Challenges
Premium
Ratings
Avidity Biosciences: Undervalued Entry Point with Promising 2025 Pipeline Despite Market Challenges
15d ago
Jefferies healthcare analyst holds an analyst/industry conference call
PremiumThe FlyJefferies healthcare analyst holds an analyst/industry conference call
3M ago
3 Best Stocks to Buy Now, 12/13/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 12/13/2024, According to Top Analysts 
3M ago
Avidity Biosciences initiated with an Outperform at RBC Capital
Premium
The Fly
Avidity Biosciences initiated with an Outperform at RBC Capital
3M ago
Avidity Biosciences Reports Strong Q3 Progress and Outlook
PremiumCompany AnnouncementsAvidity Biosciences Reports Strong Q3 Progress and Outlook
4M ago
Avidity Biosciences reports Q3 EPS (65c), consensus (71c)
Premium
The Fly
Avidity Biosciences reports Q3 EPS (65c), consensus (71c)
4M ago
RNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RNA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100